Dvago Logo
    location icon

    rightArrow
    Dvago Logo

    Delivers in

      location icon

      rightArrow
      Dvago

      Gen-M Ds Dry Suspension 30Ml

      Rs. 289.05

      Rs. 304.26

      |

      QUICK DELIVERY

      Gen-M Ds Specification

      Requires Prescription (YES/NO)

      Yes

      Generics

      Artemether , Lumefantrine

      Used For

      Malaria

      How it works

      Both components Artemether/ Lumefantrine have their own action site in the malarial parasite. The presence of the endoperoxide bridge in Artemether (generating single oxygen and free radicals, those are very cytotoxic to the plasmodia) appears to be essential for antimalarial activity.

      Gen-M Ds Usage And Safety

      Dosage

      Artemether , Lumefantrine

      Side Effects

      Very Common: Palpitations, headache, dizziness, abdominal pain, anorexia, vomiting, nausea, arthralgia, mylagia, asthenia, fatigue, sleep disorders.Common: Amnesia, paraesthesia, diarrhea, pruritus, rash, cough, electrocardiogram QT prolongation, gait disturbances, insomia.Uncommon: Liver function test increased, clonus, hypoesthesia, ataxia, somnolence.

      Drug Interactions

      CYP3A4 inhibitors (e.g. erythromycin, ketoconazole, itraconazole, cimetidine, HIV protease inhibitors, etc.) , CYP2D6 inhibitors (e.g. flecainide, metoprolol, imipramine, amitryptyline, clomipramine, etc.) , Mefloquine.

      Indication

      Used in the treatment of Malaria.

      When not to Use

      It is contraindicated to those patients which have a history of hypersensitivity to Artemether / Lumefantrine.

      Gen-M Ds Precautions

      Precaution

      Due to limited data on safety and efficacy, Artemether+Lumefantrine should not be given concurrently with any other anti-malarial agent unless there is no other treatment option.

      Gen-M Ds Warnings

      Warning 1

      Caution is advised when administering Artemether + Lumefantrine to patients with severe renal, hepatic or cardiac problems. In such cases, monitoring of the ECG is recommended and steps should be taken to correct any electrolyte disturbances.

      Warning 2

      Caution is recommended when combining Artemether + Lumefantrine with drugs exhibiting variable patterns of inhibition, induction or competition for CYP3A4 as the therapeutic effects of some drugs could be altered.

      Warning 3

      Patients who remain averse to food during treatment should be closely monitored as the risk of recrudescence may be greater.

      Gen-M Ds Additional Information

      Pregnancy category

      Always consult your physician before using any medicine.

      Storage (YES/NO)

      Store this medicine at room temperature, away from direct light and heat.

      Related Products